Phibro Animal Health Corporation PAHC

$ 22.37 -3.49%

Quarterly report 2024-Q1
added 05-08-2024

Country	USA
IPO year	2014
Industry	Drug manufacturers
Stock Exchange	NASDAQ GLOBAL SPB
CEO	Mr. Jack Bendheim
Employees in the company	1 700

Shares	40.5 M
Market Cap^[1]	$ 906 M
EBITDA (LTM)	$ 88.9 M
P/E (LTM)	59.24
P/S (LTM)	0.7
EPS (LTM)	0.29

Other stocks of industry "Drug manufacturers"

	Issuer	Price	% 24h	Market Cap	Exchange	Country
	AcelRx Pharmaceuticals ACRX	$ 0.86	7.5 %	$ 6.35 M	Nasdaq Global Market	USA
	Amryt Pharma plc AMYT	$ 14.7	-	$ 621 M	Nasdaq Global Select Market	Britain
	Aerie Pharmaceuticals AERI	$ 15.25	-	$ 754 M	Nasdaq Global Market,SPB	USA
	PetIQ PETQ	$ 13.6	1.64 %	$ 400 M	Nasdaq Global Select Market,SPB	USA
	Agile Therapeutics AGRX	$ 0.6	10.11 %	$ 58.2 M	Nasdaq Capital Market	USA
	Teligent, Inc. TLGT	$ 0.173	-13.85 %	$ 16.1 M	Nasdaq Global Select Market	USA
	Recro Pharma REPH	$ 1.4	-4.76 %	$ 65.3 M	Nasdaq Global Select Market	USA
	Athenex ATNX	$ 0.2	-23.39 %	$ 1.76 M	Nasdaq Global Select Market	USA
	PLx Pharma PLXP	$ 0.09	-27.8 %	$ 2.56 M	Nasdaq Capital Market	USA
	Shineco, Inc. TYHT	$ 11.09	-3.90 %	$ 97.2 M	Nasdaq Global Select Market	China
	Elanco Animal Health Incorporated ELAN	$ 12.55	-0.4 %	$ 6.18 B	NYSE,SPB	USA
	Lannett Company LCI	$ 0.66	1.15 %	$ 7.11 M	NYSE	USA
	Calliditas Therapeutics AB (publ) CALT	$ 40.0	-0.1 %	$ 2.03 B	Nasdaq Global Select Market	Schweden
	GW Pharmaceuticals plc GWPH	$ 218.96	-	$ 6.81 B	Nasdaq Global Select Market	Britain
	Adamas Pharmaceuticals, Inc. ADMS	$ 8.22	-	$ 376 M	Nasdaq Global Market	USA
	Pacira BioSciences PCRX	$ 16.64	0.39 %	$ 769 M	Nasdaq Global Select Market,SPB	USA
	ProPhase Labs PRPH	$ 2.18	2.83 %	$ 34.5 M	Nasdaq Capital Market	USA
	Flexion Therapeutics, Inc. FLXN	$ 9.12	-	$ 459 M	Nasdaq Global Market	USA
	Happiness Biotech Group Limited HAPP	$ 4.5	1.35 %	$ 17.8 M	Nasdaq Capital Market	China

References

Pavone, P. (2019). Market capitalization and financial variables: Evidence from Italian listed companies. International Journal of Academic Research Business and Social Sciences, 9(3), 1356-1371.